BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

MilliporeSigma and Promega Forge Strategic Partnership to Advance Next-Generation Drug Discovery

Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies. Aims to improve researcher acces...

November 04, 2025 | News

Suvoda Launches Unified Patient App to Simplify Clinical Trial Participation and Boost Retention

Suvoda (recently merged under common ownership with Greenphire), a global clinical trial technology company specializing in software solutions t...

October 30, 2025 | News

Thermo Fisher to Acquire Clario for US$8.9 Billion to Expand Digital and AI-Driven Clinical Trial Capabilities

Expected to be immediately accretive to Adjusted Earnings Per Share (EPS)¹ after close Attractive return profile given high growth and strong margin ...

October 30, 2025 | News

Swiss Rockets Secures Global License for MGI CoolMPS Sequencing Platform to Advance Multi-Omics Innovation

Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced that they entered into a exclusive license agreement with MGI Tech and Complete Genomi...

October 29, 2025 | News

Curia Invests $4 Million to Upgrade API Aseptic Suites in Spain to Meet New EU GMP Annex 1 Standards

Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million investmen...

October 28, 2025 | News

USP Launches New Solutions to Strengthen Quality Assurance for GLP-1 Receptor Agonists

The U.S. Pharmacopeia (USP) has launched a new set of solutions to support product quality for manufacturers of glucagon-like peptide-1 (GLP-1) r...

October 24, 2025 | News

Cambrex Announces $120 Million U.S. Expansion to Strengthen API Manufacturing and Peptide Therapeutics Capabilities

Cambrex, a leading global contract development and manufacturing organization (CDMO), announced a $120 million investment to expand i...

October 23, 2025 | News

Thermo Fisher’s PPD Business Launches Carbon Calculator to Drive Sustainable Clinical Research

New tool helps sponsors measure, manage and minimize the environmental impact of research The PPD™ clinical research business of Thermo Fisher Scien...

October 22, 2025 | News

Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities

Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced that it has successfully completed the acquisition of Prothya Biosolutions ...

October 21, 2025 | News

ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta

Dedicated facilities for gelatin and HPMC; 200+ jobs; operations targeted for early 2027; expands ACG's 25-year U.S. presence ACG, the world's most integr...

October 21, 2025 | News

10x Genomics and Anthropic Partner to Bring Conversational AI to Single Cell and Spatial Biology

Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making adva...

October 21, 2025 | News

Aurion Biotech Data Supports Advancing High-Dose AURN001 Regenerative Cell Therapy to Phase 3 Trial in 2026

Data strongly supports advancing high dose AURN001 regenerative cell therapy for patients with corneal endothelial disease to pivotal Phase 3 trial in H1...

October 20, 2025 | News

Merck Presents Longer-Term Phase 3 Data Showing Pimicotinib Achieves 76.2% Objective Response Rate in TGCT

With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2% Global Phase 3 MANEUVER study de...

October 20, 2025 | News

Thermo Fisher Partners with OpenAI to Accelerate Drug Development through Artificial Intelligence

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s pro...

October 17, 2025 | News

Stay Connected